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Abstract
Background: The problem of nonadherence to therapy is a key reason of insufficient asthma control. Evaluating
the beliefs about asthma medication, cognitive and emotional perceptions may help to identify patients with poor
adherence to treatment in clinical practice which need additional attention in order to increase the likelihood of them
taking their asthma medication according to the prescribed treatment protocol. The purpose of this study is to assess
whether beliefs about asthma medication, cognitive and emotional factors are related to poor treatment adherence
of asthma medication in a sample of asthma patients in Latvia.
Methods: Study subjects were asthma patients attending outpatient pulmonologist consultations in Latvia during
September 2013 to December 2015. Beliefs about asthma medicine, cognitive and emotional factors related to
asthma were determined in a cross-sectional, self-administered survey. The validated Beliefs about Medicines
Questionnaire (BMQ) and the Brief Illness Perception Questionnaire (brief IPQ) were used. Treatment adherence was
assessed using 5-item version of the Medication Adherence Reporting Scale (MARS). The total sample size was 352
patients. Logistic regression models were used to predict poor adherence to asthma treatment. The validity of each
logistic regression model was assessed by the Hosmer/Lemeshow test. The main outcome measure was self-reported
adherence to treatment.
Results: The more the patients agreed with the statement “My future health depends on my asthma medication” the
lower the possibility of poor adherence to asthma treatment (OR 0.42; 95% CI 0.24–0.74). The more concerned the
patients were in regard to long-term effects of their medication (OR 2; 95% CI 1.22–3.27), the higher the probability of
poor treatment adherence.
Conclusions: Screening asthma patients using the BMQ may help to identify those to benefit from interventions
targeting their concerns and medication beliefs in order to improve adherence to asthma medication.
Keywords: Medication adherence, Cognition, Outpatients, Asthma, Latvia
Background
The problem of non-adherence to the therapy is one of
the main reasons of insufficient asthma control [1–3].
Studies assessing treatment plans in asthma patients
have revealed that adherence to medication range
between 30 and 70% [4–6]. Several factors related to
*Correspondence: dzs14464@me.com
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the patient, to the disease, treatment or physician–
patient relationship have been identified to be related
with adherence in asthma and other diseases [7–12].
According to the self-regulation theory, both illness
perception and medication beliefs are associated with
medication adherence [13, 14]. Particularly beliefs
about illness, the necessity and the concerns (side
effects and addition) of the pharmaceutical treatment
have been identified to be the two most important
elements in the proposed theory [13–16]. Other
factors that impact adherence to treatment are cost
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of therapy, perceived efficacy of medicines, complex
dosing regimens. Cost of treatment might be of
particular concern for asthma patients in Latvia since
the reimbursement level for asthma medication is 75%
of the total medication cost.
Evaluating the beliefs about asthma medication,
cognitive and emotional perceptions may help to
identify patients with poor adherence to treatment in
clinical practice. That would guide additional attention
helping to increase the likelihood of taking asthma
medication appropriately. However, only limited
information is available on treatment adherence
in Latvian asthma patients. Furthermore, evidence
identifying medication beliefs, cognitive or emotional
factors associated with asthma medication adherence
among Latvian population is currently not available.

Aim of the study
The aim of this study was to investigate whether beliefs
about asthma medication, cognitive and emotional
factors are related to poor adherence of asthma
medication in a sample of Latvian asthma patients.
Method
Study population

The study population of this cross-sectional patient
survey consisted of asthma patients attending
outpatient pulmonologist consultations in Latvia.
The data were gathered during a period of 28 months
from September 2013 to December 2015. In a first
step, a list of all pulmonologists from the database of
the National Health Service of the medical doctors
that have contractual rights to prescribe reimbursed
medicines was acquired. Then, pulmonologist practices
in medical centres and hospitals in Riga and in bigger
towns of Latvia were selected and invited to join
the study. 15 of these practices agreed to participate
(convenience sample). These 15 medical centres employ
66 pulmonologists that is 51% of all 129 pulmonologists
in Latvia that have a contract with NHS. We
assumed these 15 practices to be representative of all
pulmonologist practices in Latvia. Each pulmonologist
was advised to invite their patients to join the survey.
Patients’ age group were 15 years and older. Patients
using controller medication–inhaled glucocorticoids in
monotherapy or in combination with long acting beta 2
mimetic medicines for at least 12 months prior to the
study were included. The sample size was calculated to
detect a prevalence of poor asthma control of 50% with
a margin of error of 5%, and a power of 95%. The total
sample size needed was 352 people.

Page 2 of 7

Assessment of main variables

A self-administered questionnaire was used to assess
socio-demographic and economic factors such as age,
education, income and sex.
Adherence to asthma medication was assessed using
5-item version of the Medication Adherence Reporting
Scale (MARS). MARS is a validated questionnaire
that has shown to have good internal, construct and
criterion validity, including correlations with objective
measures of adherence (electronic monitoring and
pharmacy dispensing data) [6, 17]. The short version of
the MARS is a five-item self-report scale for assessment
of adherent behavior that includes assessment of:
• unintentional non-adherent behavior
“I forgot to take them”, (item 1) and
• intentional non-adherent behavior
“I alter the dose”, (item 2).
“I stop taking them for a while”, (item 3).
“I decide to miss out a dose”, (item 4).
“I take less than instructed”, (item 5).
Each item was answered using a five-graded response
scale, ranging from very often (1) to never (5). Low
scores indicate low levels of adherent behavior [18].
Medication beliefs were assessed using the five items
of greatest relevance to asthma medication adapted
from the BMQ, a validated tool across many disease
conditions [19]. The specific–necessity scale contains
5 items that assess patients’ beliefs about specific
necessity to take prescribed chronic medications. All
three questions assessing patients’ beliefs about specific
necessity to take prescribed chronic medications or
concerns were selected from the original BMQ. All
belief items had Likert scale responses.
The Brief Illness Perception Questionnaire (brief IPQ)
was used to obtain information on illness perception of
the study participants. The Brief IPQ consists of eight
items and a causal question [20, 21]. All of the items
except the causal question are rated using a 0-to-10
response scale. Five of the items assess cognitive illness
representations: consequences (item 1), timeline (item
2), personal control (item 3), treatment control (item 4),
and identity (item 5). Two of the items assess emotional
representations: concern (item 6) and emotions (item
8). One item assesses illness comprehensibility (item 7).
Assessment of the causal representation is by an openended response, which asks patients to list the three
most important causal factors in their illness (item 9).
Statistical analysis

The Statistical Package for the Social Sciences (SPSS)
IBM 21.0 was used to analyse the data. Means, standard
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deviations, and frequencies are presented to describe the
characteristics of the study sample. A cutoff point of > 6
for MARS-5 was used to define poor medical adherence.
The answers of the BMQ were dichotomized into (i) “I
agree/I completely agree” and (ii) “Not sure/I disagree/I
completely disagree”. The logistic regression analyses
were first conducted for each variable alone. In the
multivariate logistic analysis, the outcome variable was
controlled for age, income and educational level. The
odds ratio and respective 95% confidence interval are
presented for all models. The validity of each logistic
regression model was assessed by the Hosmer/Lemeshow
test.

Results
The baseline characteristics of the study population are
presented in Table 1.
The majority of the patients had vocational education
and were earning at least 300 euros per month. Two out
of three patients were using glucocorticoids and onethird a combination therapy consisting of glucocorticoids
and a beta 2 mimetic drug. The prevalence of poor
treatment adherence was 58.1% in men and 68.7% in
women.
We observed that monotherapy with corticosteroids
reduced the odds of poor treatment adherence whereas
fixed-dose combination medications containing a
corticosteroid and a beta 2 mimetic increased the odds of
poor treatment adherence.

Table 1 Baseline characteristics of the study sample

Age, mean (SDa)

Men

Women

Total

(n = 85)

(n = 264)

(n = 352)

Table 2 Odds ratio of socio-demographic and economic
factors in regard poor treatment adherence
MARS 5-item scale
Univariate
ORa

53.7 (17.4) 58.7 (16.6) 57.5 (16.9)
3.5

7.5

Age

0.98

(0.97–1.00)

Female sex

1.58

(0.96–2.60)

Education

Secondary

23.3

27.1

26.1

Vocational

47.7

28.9

33.5

Basic or secondary

1

ref

Higher

25.6

36.5

33.8

Vocational

1.79

(1.03–3.11)

Higher

1.27

(0.75–2.16)

16.7

25.3

23.2

Income%
  < 300 €/month
300–550 €/month

36.9

48.2

45.5

550–750 €/month

28.6

18.3

20.8

17.9

8.2

10.6

  > 750 €/month
Asthma medication%
Glucocorticoids

Income
  < 300 €/month

1

ref

300–550 €/month

0.86

(0.48–1.55)

550–750 €/month
  > 750 €/month

0.80

(0.41–1.59)

0.87

(0.38–2.03)

Asthma medication

62.8

63.4

63.3

Glucocorticoids+beta 2 mimetic 33.7

33.2

33.3

Corticosteroids

0.57

(0.35–0.91)

66.1

Corticosteriods+beta 2 mimetic

1.93

(1.18–3.16)

Poor treatment adherence%
(MARS-5 item scale)
a

(95% CIb)

6.5

Education%
Basic

None of the socio-demographic or socio-economic
factors were predictors of poor treatment adherence
(Table 2). Vocational level of education seemed to
increase the odds to have poor treatment adherence.
Table 3 shows the odds ratio of the association
between cognitive and emotional illness indicators with
poor treatment adherence. Apparently, none of these
indicators were able to predict poor treatment adherence
in Latvian asthma patients.
Several beliefs about medication were identified
as predictors of poor treatment adherence (Table 4).
Asthma patients who were convinced that their future
health depended on the asthma treatment were less
likely to have poor treatment adherence (OR 0.42: 95%
CI 0.24–0.74). In case the patient was concerned by the
long-term effects of their asthma medication the odds
of poor treatment adherence were 2 (95% CI 1.22–3.27).
Furthermore, patients who were concerned by the need
to constantly use their asthma medication seemed to
have increased odds to have poor treatment adherence,
but the association was not statistically significant.
In addition, we conducted a correlation analysis
between the two variables of the BMQ questionnaire
that were statistically significant predictor of treatment
adherence. However, no statistically significant
correlation was observed (r = 0.068; p value 0.199).

Standard deviation

58.1

68.7

a

Odds ratio

b

Confidence interval
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Table 3 Odds ratio of the association of cognitive and emotional illness indicators and poor treatment adherence
MARS 5-item scale
Mutivariatec

Univariate
ORa

(95% CIb)

OR

(95% CI)

How much does your illness affect your life?

0.96

(0.88–1.05)

0.96

(0.88–1.05)

How long do you think your illness will continue?

0.96

(0.87–1.05)

0.98

(0.89–1.08)

How much control do you feel you have over your illness?

0.98

(0.89–1.08)

0.98

(0.88–1.08)

How much do you think your treatment can help your illness?

0.96

(0.86–1.07)

0.96

(0.85–1.07)

How much do you experience symptoms from your illness?

1.01

(0.93–1.10)

1.01

(0.92–1.11)

How concerned are you about your illness?

0.99

(0.93–1.07)

1.01

(0.94–1.09)

How well do you feel you understand your illness?

1.06

(0.98–1.15)

0.98

(0.97–1.15)

How much does your illness affect you emotionally?

1.03

(0.96–1.10)

1.03

(0.96–1.11)

a

Odds ratio

b

Confidence interval

c

Adjusted for age, education and income

Table 4 Odds ratio of the association between medication beliefs and poor treatment adherence
MARS 5-item scale
Mutivariatec

Univariate
ORa

(95% CIb)

OR

(95% CI)

Necessity
My health is fully dependent on the asthma medication

0.58

(0.36–0.94)

0.61

(0.37–1.01)

Without asthma medication my life would be impossible

0.64

(0.41–1.01)

0.62

(0.38–1.01)

Without my asthma medication I would be very ill

0.71

(0.45–1.12)

0.72

(0.44–1.19)

My future health depends on my asthma medication

0.42

(0.25–0.70)

0.42

(0.24–0.74)

My controlling asthma medication prevents health deterioration

0.51

(0.28–0.96)

0.61

(0.32–1.17)

Concerns

a

I am concerned by the need to constantly use my asthma medication

1.69

(1.07–2.68)

1.59

(0.98–2.57)

I am sometimes concerned by long term effects of my asthma medication

1.89

(1.19–3.01)

2

(1.22–3.27)

My asthma medication is incomprehensible to me

1.03

(0.60–1.79)

1.27

(0.70–2.29)

Odds ratio

b

Confidence interval

c

Adjusted for age, education and income

Discussion
Our study revealed that several beliefs about asthma
medication were predictors of poor treatment adherence
in Latvian asthma patients. However, none of the
indicators of illness perception seemed to be associated
with suboptimal adherence. Moreover, it is of concern
that only three out of ten asthma patients in Latvia had
adequate treatment adherence during the timeframe of
our study.
Latvia differs from other countries in access to
medicines. The reimbursement level for asthma
medication in Latvia is 75% of the pharmacy price and
therefore patient’s co-payment for a monthly supply of a

controller medication was 1452 EUR for the most widely
used medicine at the time of the study. It is a significant
amount relative to the reported income of our study
subjects. We may speculate that significant financial
burden is a factor of low total adherence in our study.
There have been previous studies that look at this factor.
A study in US assessed impact of a full reimbursement
of medication used after myocardial infarction compared
to a usual reimbursement plan [22]. The results showed 4
to 6 percentage points higher adherence rate in the fullcoverage group.
The prevalence of poor adherence in Latvian asthma
patients is higher than reported in previous research
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[6–8] whereas poor adherence to asthma treatment was
found to be 60% in the USA and was ranging between
30 and 40% in France, Germany and Italy [6]. Several
intentional and non-intentional factors have been shown
to be related to poor treatment adherence [7–9]. Some
factors are related to the patient, others to the disease,
treatment or physician–patient relationship [10, 11].
Patients’ medication beliefs may explain a significant
portion of variation in medication non-adherence
in asthma patients [12]. Our results in regard beliefs
about medication and treatment adherence are in
line with previous findings showing that beliefs about
the necessity and the concerns about side effects of
the asthma treatment are well associated with poor
adherence (Leventhal et al. 2005); [14–16]. A British
study in 100 community-based patients showed that
non-adherent behaviours were associated with doubts
about the necessity of medication and concerns about
its potential adverse effects [14]. Furthermore, a crosssectional survey among 238 Dutch asthma patients
also reported that self-reported adherence correlated
significantly with necessity beliefs and concerns of
chronic use of inhaled corticosteroids [16]. These beliefs
and concerns against perceptions of necessity have
been found to predict adherence to medication not
only in asthma patients but also in treatment of HIV,
arthritis and coronary heart disease [15, 16, 23, 24]. In
addition, current evidence suggests that certain beliefs
about medicines are more predictive of intentional
non-adherence than of unintentional non-adherence
[15]. For instance, in a study among asthma patients in
New Zealand intentional non-adherence (missing or
altering doses to suit one’s needs) is associated with
decision balance, whereas unintentional non-adherence
(forgetting to take medication) is less strongly associated
with decision balance and is more strongly associated
with demographics, in particular age [18].
Patients often make treatment choices according to
their own understanding and beliefs about the illness
and treatment. Patients’ adherence to medication is
particularly influenced by the way in which they evaluate
their personal need for medication relative to their
concerns about potential negative effects of taking it. Our
finding that using fixed-dose combination medications
containing a corticosteroid and a beta 2 mimetic
increased the odds of poor treatment adherence might
seem a paradoxical result since fixed dose combination
medicines of inhaled corticosteroid and bet 2 mimetic
offer treatment effect that a patient can feel, whereas
effects of plain corticosteroid a patient would not usually
feel as it will reduce number of disease exacerbations
over time. However, we may speculate that the symptom
relieving effect of the beta 2 mimetic component of the
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medicine is indeed causing non-adherent behaviour.
Patients would feel their symptom relief brought by the
beta 2 mimetic component of their medicine and that
would shift the necessity-concern balance in the patient’s
perception. They would decide that their disease is not
that severe anymore and the resulting action would be
taking less medicine.
National Institute of Clinical Excellence (NICE)
guidance recommends addressing any beliefs and
concerns that patients have that result in reduced
adherence by uncovering individual’s perceptions of
their medication during the consultation [25]. BMQ is a
useful tool to assess medication beliefs and concerns and
we recommend using at least some questions of BMQ
routinely if not all of the questionnaire in the clinical
practice.
The self-regulatory model was developed in order to
explain illness-related behaviour, including adherence
to treatment recommendations within the field of noncommunicable diseases [13]. According to that model
adherence to treatment consists of several components
that the patient can adopt to cope with their disease.
Only a few studies have assessed the association between
illness perception and treatment adherence in asthma
patients [14, 26]. In contrast to our study, non-adherent
behaviours were associated with more negative perceived
consequences of illness in a British study conducted
among 100 asthma patients [14]. Furthermore, in a
large Polish survey of 3618 asthma patients, illness
perception, younger age, disease duration and severity
were predictors of adherence to treatment with
fluticasone propionate and formoterol fumarate [26]. It
has also been suggested that interventions focusing on
illness perception helped to support chronic obstructive
pulmonary disease patients in their disease management
and to improve health-related quality of life [27]. More
evidence is needed to show whether the same principle
applies for asthma patients.
Naturally, several limitations may be considered.
Asthma medication adherence was measured by a
self-report questionnaire not previously validated in
the Latvian population. Self-reported measurements
of medication adherence may not be that precise and
are subject to self-presentational and recall biases.
However, MARS is a validated questionnaire that has
shown to have good internal, construct, and criterion
validity, including correlations with objective measures
of adherence (electronic monitoring and pharmacy
dispensing data) [6, 17]. In addition, as this study is
cross-sectional in design, no conclusions about an
association between cause and effect can be taken. Even
though the patients of this study were recruited from
the main towns and the capital city where the majority
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of the Latvian population live, it seems that this could
over-represent urban populations and underrepresent
rural populations and the results cannot be generalized
to the overall population of Latvian asthma patients.
Finally, the study addresses medication adherence
related to frequency of medication use as per doctors’
prescription but does not address medication non
adherence due to incorrect inhaler technique which is
another important factor for receiving the appropriate
dose of medicine.

Conclusion
In conclusion, screening of asthma patients to assess
their beliefs about their asthma medication may help
to identify those ones to benefit from interventions
targeting their concerns in order to improve treatment
adherence. Many of the common beliefs of the Latvian
asthma patients could be modified by educational
interventions performed within the primary healthcare system. This may have the potential to significantly
reduce the economic burden related to poor asthma
control and improve the quality of life of asthma
patients in a cost-effective way.
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